Skip to content

Clinical trials

Phase 3 Urologic Diseases trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urologic Diseases Phase: Phase 3 Country / region: Australia Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20191
20201
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting3
Completed1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Astellas Pharma Europe Ltd.1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urologic Diseases5
Kidney Diseases4
Glomerulonephritis3
Glomerulonephritis, IGA3
Renal Insufficiency, Chronic3
Autoimmune Diseases1
Female Urogenital Diseases1
Female Urogenital Diseases and Pregnancy Complications1
Genetic Diseases, Inborn1
Hyperoxaluria, Primary1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.